Letters Section Editor: Robert M. Golub,
MD, Senior Editor.
To the Editor: In their study of the consequences
of exceeding a drug benefit cap, Dr Tseng and colleagues1 found
that some patients with chronic diseases discontinued prescribed medications
for financial reasons. The authors concluded that clinicians, insurers, and
the public need to consider strategies to maximize benefit from Medicare drug
coverage plans and mentioned reimportation of prescription drugs as a possibility.
However, alternatives exist that may help reduce drug expenses.
Bjarnason NH, Kampmann JP. Medicare Drug Beneficiaries and Cost-Lowering Strategies. JAMA. 2005;293(5):552-553. doi:10.1001/jama.293.5.552-b